23andMe Secures More Than $22M In Series C Financing Round

23andMe Inc. closed its Series C financing round with more than $22 million. The round includes new investors, such as Johnson & Johnson Development Corp., in the California-based genetics company. Existing investors, including New Enterprise Associates and Google Ventures, also participated.

North AmericaUSBriefs